• 1
    Persson CGA, Erjefält JS. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. TIPS 1997;18:11723.
  • 2
    Persson CGA, Erjefält JS, Andersson M, et al. Epithelium, microcirculation and eosinophils – new aspects of the allergic airway in vivo. Allergy 1997;52:24155.
  • 3
    Erjefált JS, Sundler F, Persson CGA. Eosinophils, ncutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med 1996;153:166674.
  • 4
    Erjefält JS, Korsgren M, Nilsson M, Sundler F Persson CGA. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin Exp Allergy 1997 (in press).
  • 5
    Erjefält JS, Greiff L, Andersson M, et al. Eosinophil lysis and clusters of free eosinophil granules (Cfegs) in rhinitis and asthma. Am J Respir Crit Care Med 1997;155:A977.
  • 6
    Fokkens WJ, Vroom TM, Gerritsma V, Rijntjes E. A mild biopsy method to obtain high-quality specimens of nasal mucosa. Rhinology 1988;26:2935.
  • 7
    Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:87783.
  • 8
    Jahnsen FL, Brandzaeg P, Halstensen TS. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J Immunol Methods 1994;175:2336.